**Author Information** An event is serious (based on the ICH definition) when the patient outcome is:\* death\* life-threatening\* hospitalisation\* disability\* congenital anomaly\* other medically important event

In a study, two infants \[*sexes not stated*\] were described, of which one infant died due to adenovirus infection and the second infant died due to acute respiratory distress syndrome (ARDS) caused by respiratory syncytial virus infection following treatment with gemtuzumab ozogamicin \[*time to reactions onsets not stated*\].

The infants, who had a history of acute myeloid leukaemia (AML), started receiving IV gemtuzumab ozogamicin 0.1 mg/kg. Following the treatment with gemtuzumab ozogamicin, both the infants achieved complete remission in AML. However, during the intensification phase I, one infant died of adenovirus infection, which led to a right sided heart failure, coagulopathyand small bowel necrosis. The second infant died of ARDS caused by respiratory syncytial virus infection during intensification phase III.

**Author comment:** *\"\[Treatment-related mortality\] occurred in 2 infants who were in \[complete remission\].\" \"One death occurred during \[intensification\] I and was due to adenovirus infection, which led to right sided heart failure, coagulopathy, and small bowel necrosis.\" \"The other death occurred during \[intensification\] III and was caused by \[acute respiratory distress syndrome\] related to respiratory syncytial virus infection.\"*
